Literature DB >> 12132299

[Simultaneous onset of pemphigoid and factor VIII antibody hemophilia].

C Maczek1, S Thoma-Uszynski, G Schuler, M Hertl.   

Abstract

A 47-year old patient who had been suffering from hypertension and chronic renal failure for many years developed progressive extensive haemorrhagic erosions of the mouth within 3 months and less severe erosions of the genital and nasal mucosa. Additionally, subcutaneous haematomas developed spontaneously. Laboratory investigations demonstrated circulating antibodies against factor VIII while direct and indirect immunofluorescent microscopy showed discrete tissue-bound and circulating IgG reactive with the epidermal basement membrane in a pemphigoid-like fashion. Immunoblot analysis of the patient's serum revealed an "atypical" IgG reactivity against a central portion of the extracellular domain of the BP180 antigen. These findings were unexpected, since the clinical aspect showed striking resemblance to (paraneoplastic) pemphigus. The patient developed life-threatening complications. Eventually, reduction of circulating autoantibodies by a combination of plasmapheresis and subsequent immunosuppressive therapy led to a stable remission of both autoimmune bullous skin disorder and acquired haemophilia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12132299     DOI: 10.1007/s001050100278

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  2 in total

1.  Acquired haemophilia heralded by bleeding into the oral mucosa in a patient with bullous pemphigoid, rheumatoid arthritis, and vitiligo.

Authors:  R S Patel; K E Harman; C Nichols; R M Burd; S Pavord
Journal:  Postgrad Med J       Date:  2006-01       Impact factor: 2.401

2.  Successful Management of Acquired Hemophilia A Associated with Bullous Pemphigoid: A Case Report and Review of the Literature.

Authors:  Quentin Binet; Catherine Lambert; Laurine Sacré; Stéphane Eeckhoudt; Cedric Hermans
Journal:  Case Rep Hematol       Date:  2017-03-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.